WHO Contraceptive eligibility for women at high risk of HIV, UPDATE

Contraceptive eligibility for women at high risk of HIV The World Health Organization (WHO) convened a Guideline Development Group (GDG) meeting from 29 to 31 July 2019 to review global guidance on contraceptive eligibility for women at high risk of HIV acquisition to...

WHO revises recommendations on hormonal contraceptive use for women at high HIV risk

WHO revises recommendations on hormonal contraceptive use for women at high HIV risk The World Health Organization (WHO) has revised its guidance on contraceptive use to reflect new evidence that women at high risk of HIV can use any form of reversible contraception,...

ECHO Trial Commentary

FP ECHO Trial Commentary The long-awaited results of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, a rigorous, three-year clinical study designed to resolve if using Depo Provera (DMPA-IM) increases women and adolescent girls’ risk of HIV, are...

ECHO Consortium Statement, UPDATE

ECHO Consortium Statement, UPDATE The updates to the ECHO Study Q&A, summarised in this statement, provide clarification on how the research protocol was developed and the ethical safeguards built into that design.       Published: 2019 Source: ECHO...

ECHO Study Q&A, UPDATE

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study Questions and Answers, August 2019 This ECHO Study Q&A was updated August 2, 2019 and includes the ECHO results as well as information about the study.       Published: 2019...